Q

Qureight jobs

Recent signal 🇬🇧 United Kingdom · Health
Latest round
$20M
30 Jul 2026
Open roles
7
5 posted in the last 30 days
Backed by
6 investors
Molten Ventures, Hargreave Hale AIM VCT and more
Hiring now

Open roles at Qureight

7 live roles, newest first
Senior Data Engineer
Cambridge, United Kingdom 19 Oct 2026 New
Apply →
Senior Clinical Data Engineer
Cambridge, United Kingdom 16 Oct 2026 New
Apply →
Clinical Site Manager
Cambridge, United Kingdom 14 Oct 2026
Apply →
Senior Clinical Data Manager
Cambridge, United Kingdom 12 Oct 2026
Apply →
Product Owner
Cambridge, United Kingdom 28 Sep 2026
Apply →
Integration and Automation Engineer
Cambridge, United Kingdom 11 Sep 2026
Apply →
Senior Machine Learning Engineer
London, United Kingdom 30 Jul 2026
Apply →
Why join

Latest Qureight Signals

What they do

Qureight has raised $20 million in Series B funding, led by Molten Ventures, to enhance its 3D deep learning imaging platform for clinical trials. The capital will be utilized to expand its operations in the lung and heart disease markets, focusing on improving clinical trial speed and design through AI-driven imaging solutions.

Why it matters

Qureight has developed an end-to-end imaging and precision endpoints platform that leverages AI to analyze complex lung and heart scans. This technology aims to streamline clinical trials by providing more accurate and efficient imaging data utilization, addressing a critical bottleneck in the pharmaceutical development process.

Traction

While specific revenue figures are not disclosed, Qureight targets pharmaceutical companies conducting clinical trials for respiratory conditions, indicating a focus on a high-value market segment. The establishment of a specialized AI imaging laboratory suggests a commitment to scaling its capabilities and enhancing service offerings in this niche.

Where the market is going

Qureight is positioned to disrupt traditional imaging solutions used in clinical trials, which often rely on outdated methodologies that hinder trial efficiency. By integrating advanced AI techniques, Qureight threatens incumbents in the medical imaging space, capitalizing on the urgent need for precision and speed in drug development, particularly in the lucrative lung and heart disease markets.

Backed by
Molten VenturesHargreave Hale AIM VCTXTX VenturesGuinness VenturesMeltwindAscension
Analysis updated 30 Jul 2026 Full deal history on MapCo →
Hiring at Qureight

Why Qureight is hiring

Qureight closed a $20M funding round in July 2026, with investors including Molten Ventures, Hargreave Hale AIM VCT, XTX Ventures and others. It currently has 7 open roles, 5 of them posted in the last 30 days, with hiring concentrated in Cambridge and London. Companies tend to grow headcount fastest in the months after a round, so now is a good time to apply.

Teams hiring

Where Qureight hires

Also hiring

Similar Health companies hiring

FAQ

Qureight jobs: common questions

Is Qureight hiring?

Yes. Qureight has 7 open roles on SuperAIJobs right now, including 5 posted in the last 30 days. The list is refreshed daily from Qureight’s own careers site.

Where are Qureight jobs located?

Most open roles at Qureight are in Cambridge and London.

Does Qureight hire remotely?

None of Qureight’s current roles are listed as remote, so expect to work from one of its offices.

How much has Qureight raised?

The latest round we track is a $20M funding round in July 2026. Investors include Molten Ventures, Hargreave Hale AIM VCT, XTX Ventures and others. See the full deal history on MapCo.

What does Qureight do?

Qureight has developed an end-to-end imaging and precision endpoints platform that leverages AI to analyze complex lung and heart scans.

How do I apply for a job at Qureight?

Every role on this page links straight to Qureight’s own application page, so you apply directly — SuperAIJobs never sits in between.